Didier Merlin

Didier Merlin is Regents' Professor at Georgia State University and Senior Research Career Scientist at the Atlanta VA Medical Center. His research focuses on inflammatory bowel disease (IBD) mechanisms and nanomedicine approaches for targeted drug delivery. With over 200 publications (H-index 82), his lab investigates intestinal peptide transporters, nanoparticle design, and non-invasive diagnostics.

Major research directions include: 1) PepT1 transporter's role in colitis aggravation through bacterial peptide uptake; 2) Development of ginger-derived nanoparticles for IBD treatment; 3) Fecal miRNA biomarkers for non-invasive IBD diagnosis.

Professor Merlin's publications demonstrate consistent innovation in translational nanomedicine, particularly through natural nanoparticle engineering and nucleic acid delivery platforms. His work bridges basic science and clinical applications for gastrointestinal disorders.

Laboratory: Develops nanotechnology platforms for oral drug delivery at Petit Science Center, with collaborations at Veterans Affairs Medical Center.